Chulalongkorn University
Pornanong Aramwit, Pharm.D., Ph.D
The objectives of this study are to evaluate efficacy and safety of artificial saliva containing cumin and ginger extract in head and neck cancer patients with xerostomia.
Xerostomia
Artificial saliva containing cumin and ginger extract
Placebo
Not Applicable
There are 52 patients in this study. They are divided into 2 groups which are artificial saliva containing cumin and ginger extract group (test group) 26 patients and placebo group 26 patients. The patients spray the sample into the mouth 3 times/day for 14 day. Amount of saliva, pH of saliva, xerostomia questionnaires, WHO Oral Mucositis Grading Scale, quality of life, adverse events, and satisfaction were assessed.}}
| Study Type : | Interventional |
| Estimated Enrollment : | 52 participants |
| Masking : | Quadruple |
| Primary Purpose : | Treatment |
| Official Title : | Efficacy and Safety of Artificial Saliva Containing Cumin and Ginger Extract in Head and Neck Cancer Patients With Xerostomia |
| Actual Study Start Date : | July 1, 2023 |
| Estimated Primary Completion Date : | August 31, 2023 |
| Estimated Study Completion Date : | September 26, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Artificial saliva containing cumin and ginger extract Artificial saliva containing cumin and ginger extract in spray bottle |
Other: Artificial saliva containing cumin and ginger extract |
|
Placebo Comparator: Placebo Placebo containing composition close to the test group without cumin and ginger extract in spray bottle |
Other: Placebo |
| Ages Eligible for Study: | 18 Years |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.